HIV-1 integrase is one of the three enzymes that are critical for replication and spread of HIV and its inhibition is one of the most promising new drug targets for anti-retroviral therapy with potential advantage over existing therapies. This paper describes the isolation and structure elucidation of exophillic acid, a novel dimeric 2,4-dihydroxy alkyl benzoic acid, derived from Exophiala pisciphila, a fungus isolated from a soil sample collected in Georgia, USA. Exophillic acid (1) and aquastatin A (2), a related compound, inhibited the strand transfer HIV-1 integrase is one of the three enzymes (protease and reverse transcriptase are the other two) that are critical for replication and spread of virus. It catalyzes three essential steps that include assembly, endonucleolytic cleavage (3'-end processing) of the viral DNA and strand transfer of the viral DNA into the host cell DNA.1-4) Inhibitors of reverse transcriptase and protease have led to a number of clinical agents that continue to have enormous impact on the control of spread of HIV-1 infection and prolongation of lives. Unfortunately, emergence of multidrug resistant virus strains particularly in drug naive patients has become a serious problem and anti-HIV-1 therapy with a new mode of action is needed. HIV-1 integrase is absent in the host cells and its essentiality for viral replication presents it to be an exceptional target for the development of a non-toxic anti-retroviral therapeutic agent. Recently much progress has been made in identification of inhibitors of this enzyme. [5] [6] [7] [8] [9] Screening of natural product extracts has discovered inhibitors and antagonists of many therapeutically relevant biological targets. Natural products have been particularly good sources of novel anti-infective agents. Screening using recombinant HIV-1 integrase (50-220AA) led to the discovery of a number of natural product inhibitors exemplified by integric acid,10,11) and cytosporic acid12).
Continued screening with the strand transfer format of the assay13) led to the discovery of a novel dimeric 2,4-dihydroxy alkyl benzoic acid trivially named exophillic acid (1), isolated from E. pisciphila. The isolation, structure elucidation and HIV-1 inhibitory activity of 1 and a related compound aquastatin A (2)14) are described herein.
Producing Organism and Fermentation
The fungus (MF6720) was isolated from a soil sample collected in Georgia, USA and was identified as E.
pisciphila by micromorphological features as described by DE HOOG15) and a microscopic picture is depicted in Figure   1 . For the production of exophillic acid, the culture was grown on a YMEJ seed medium followed by vermiculite based solid production media as described in the experimental section.
Isolation of Exophillic Acid (1) The fermentation broth of E. pisciphila was extracted with methyl ethyl ketone and was chromatographed on preparative silica gel plates followed by reversed phase HPLC (Scheme 1) to furnish exophillic acid 1 (400mg/ liter) as a buff colored solid.
Structure Elucidation of Exophillic Acid (1) High-resolution ESIFTMS analysis of 1 produced a turn showed correlations to protons buried in methylene envelop. The anomeric proton (H-1") of the hexose residue showed a 7.8Hz coupling with H-2" which exhibited a In summary, we have described isolation and structure of exophillic acid (1), a novel dimeric alkyl-benzoate glucoside, which is a modest inhibitor of the strand transfer reaction of HIV-1 integrase.
Experimental
General Procedure
All NMR spectra were recorded on Varian Inova 500 or 600MHz instruments operating at 500 and 600MHz for 1H and 125 and 150MHz for 13C nuclei. An HP1100 was used for analytical HPLC. LC-MS was performed on a Thermo Quest LCQ instrument using electrospray ionization (ESI) or atmospheric pressure chemical ionization (APCI). High
Resolution mass spectral analyses were performed on a Thermo Quest FTMS using electrospray ionization. For column chromatography silica gel H (E. Merck 60-200 mesh) was used. 
